High-fat diet rescues lethality of homozygous knock-in R155H VCP myopathic mice
高脂肪饮食挽救纯合敲入 R155H VCP 肌病小鼠的致死率
基本信息
- 批准号:8534709
- 负责人:
- 金额:$ 17.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:Amyotrophic Lateral SclerosisAnimal ModelAnimalsAutophagocytosisAutophagosomeBiochemicalBrainClinicalCoconut OilDevelopmentDietDiseaseDisease ProgressionExhibitsFatty AcidsFatty acid glycerol estersFrontotemporal DementiaGenesHeterozygoteHomozygoteHumanInclusion BodiesInheritedKnock-in MouseLaboratoriesLifeMethodsMitochondriaModelingMolecularMonitorMusMuscleMuscle WeaknessMutationMyoblastsMyocardiumMyopathyOsteitis DeformansPathogenesisPathologyPathway interactionsPatientsPhenotypeReportingSignal PathwaySignal TransductionSourceSpinal CordSystemTestingTherapeuticUbiquitinWeaningWeightdisease phenotypefeedinghuman diseasemitochondrial autophagymouse modelmulticatalytic endopeptidase complexmuscle strengthnoveloffspringpreclinical studypregnantprotein degradationpublic health relevancepupresponsevalosin-containing protein
项目摘要
DESCRIPTION (provided by applicant): Our laboratory was the first to identify VCP mutations as a cause of hereditary inclusion body myopathy, Paget's disease of bone, frontotemporal dementia and amyotrophic lateral sclerosis, and has made progress in identifying the underlying molecular pathogenesis of these diseases. Studies of patients' myoblasts and the heterozygous R155H mouse have placed VCP at the intersection of the ubiquitin-proteasome signaling and autophagy pathways, both mechanisms being considered responsible for the intracellular protein degradation and abnormal pathology seen in muscle and brain. We have developed the first knock-in VCP mouse model carrying the common R155H mutation, which has many clinical features typical of the human disease (1). Unlike disease progression in the R155H heterozygous (VCPR155H/+) mouse model, homozygotes (VCPR155H/R155H) have a more severe muscle, brain and spinal cord pathology, with most surviving no more than 21 days. Homozygotes demonstrate an abnormal autophagic pathway and mitochondrial proliferation, as evidenced by structural and functional studies. Recent preliminary studies have shown that feeding pregnant heterozygous dams a diet with a 3% increase in fat results in a dramatic improvement in the survival of their homozygous offspring. These offspring live longer than 21 days and are successfully weaned, demonstrating that an increased fat diet ameliorates the lethal phenotype. In this application, we propose to investigate the optimum percentage of fat content on further rescuing the lethal phenotype. We will also study the important altered mitochondrial, autophagy and ubiquitin-proteasome molecular pathways in the homozygous VCP knock-in mice treated with normal versus high-fat diets. Studying this observation affords the opportunity to develop a promising therapeutic strategy for patients with VCP and related diseases.
描述(由申请人提供):我们实验室是第一个确定VCP突变是遗传性包涵体肌病、佩吉特骨病、额颞叶痴呆和肌萎缩侧索硬化症的原因,并在确定这些疾病的潜在分子发病机制方面取得了进展。对患者成肌细胞和杂合子R155 H小鼠的研究已经将VCP置于泛素-蛋白酶体信号传导和自噬途径的交叉点,这两种机制被认为是导致细胞内蛋白质降解和肌肉和大脑中观察到的异常病理学的原因。我们开发了第一个携带常见R155 H突变的基因敲入VCP小鼠模型,该模型具有许多人类疾病的典型临床特征(1)。与R155 H杂合(VCPR 155 H/+)小鼠模型中的疾病进展不同,纯合子(VCPR 155 H/R155 H)具有更严重的肌肉、脑和脊髓病理学,大多数存活不超过21天。结构和功能研究表明,纯合子表现出异常的自噬途径和线粒体增殖。最近的初步研究表明,给怀孕的杂合子母鼠喂食脂肪含量增加3%的饮食,可以显著提高其纯合子后代的存活率。这些后代的寿命超过21天,并成功断奶,表明增加脂肪饮食改善了致死表型。在本申请中,我们建议研究脂肪含量的最佳百分比以进一步挽救致死表型。我们还将研究正常与高脂饮食处理的纯合子VCP基因敲入小鼠中重要的线粒体、自噬和泛素-蛋白酶体分子途径的改变。研究这一观察结果为VCP和相关疾病患者提供了一个有前途的治疗策略。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
- DOI:10.1371/journal.pone.0122888
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Nalbandian A;Llewellyn KJ;Nguyen C;Yazdi PG;Kimonis VE
- 通讯作者:Kimonis VE
Expression level of R155H mRNA in the knock-in mouse model.
敲入小鼠模型中 R155H mRNA 的表达水平。
- DOI:10.1016/j.bbrc.2020.01.021
- 发表时间:2020
- 期刊:
- 影响因子:3.1
- 作者:Cheng,Cheng;Weiss,Lan;Ta,Lac;Kimonis,Virginia
- 通讯作者:Kimonis,Virginia
A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy.
- DOI:10.1371/journal.pone.0131995
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Llewellyn KJ;Walker N;Nguyen C;Tan B;BenMohamed L;Kimonis VE;Nalbandian A
- 通讯作者:Nalbandian A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA Eunice KIMONIS其他文献
VIRGINIA Eunice KIMONIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA Eunice KIMONIS', 18)}}的其他基金
Antisense oligonucleotide treatment for Pompe disease
庞贝病的反义寡核苷酸治疗
- 批准号:
10433785 - 财政年份:2022
- 资助金额:
$ 17.65万 - 项目类别:
Antisense oligonucleotide treatment for Pompe disease
庞贝病的反义寡核苷酸治疗
- 批准号:
10652582 - 财政年份:2022
- 资助金额:
$ 17.65万 - 项目类别:
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseases
用于罕见遗传性脑部疾病组合治疗的工程 AAV 载体
- 批准号:
10414342 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Translational Studies of Lipidomics-Associated Signaling Pathways in VCP Disease
VCP 疾病中脂质组学相关信号通路的转化研究
- 批准号:
8912058 - 财政年份:2014
- 资助金额:
$ 17.65万 - 项目类别:
High-fat diet rescues lethality of homozygous knock-in R155H VCP myopathic mice
高脂肪饮食挽救纯合敲入 R155H VCP 肌病小鼠的致死率
- 批准号:
8364893 - 财政年份:2012
- 资助金额:
$ 17.65万 - 项目类别:
INCLUSION BODY MYOPATHY ASSOPCIATED WITH APAGET DISEASE OF BONE AND FRONTOTEMPOR
与Apaget骨病和额颞叶病相关的包涵体肌病
- 批准号:
8166932 - 财政年份:2009
- 资助金额:
$ 17.65万 - 项目类别:
PRADER-WILLI SYNDROME AND EARLY-ONSET MORBID OBESITY NATURAL HISTORY CLINICAL PR
普瑞德威利综合征和早发性病态肥胖自然史临床公关
- 批准号:
8166923 - 财政年份:2009
- 资助金额:
$ 17.65万 - 项目类别:
CHARACTERIZATION OF FAMILIAL MYOPATHY, PAGET DISEASE OF BONE
家族性肌病、佩吉特骨病的特征
- 批准号:
8166942 - 财政年份:2009
- 资助金额:
$ 17.65万 - 项目类别:
PRADER-WILLI SYNDROME AND EARLY-ONSET MORBID OBESITY NATURAL HISTORY CLINICAL PR
普瑞德威利综合征和早发性病态肥胖自然史临床公关
- 批准号:
7951066 - 财政年份:2008
- 资助金额:
$ 17.65万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 17.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists